1999
DOI: 10.1097/00002060-199909000-00004
|View full text |Cite
|
Sign up to set email alerts
|

Comorbidities in Stroke Patients as Assessed With a Newly Developed Comorbidity Scale1

Abstract: We previously reported reliability and validity of our newly developed comorbidity scale (CS) for stroke outcome research based on a retrospective sample. The objectives of this study were to cross-validate the comorbidity scale in a new prospective sample and to investigate longitudinal changes of the comorbidity scale during hospitalization. In a prospective sample of 175 stroke patients admitted to five nonacute rehabilitation hospitals in Japan, we analyzed the frequency and grading of comorbidities and co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
41
0

Year Published

2001
2001
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 49 publications
(43 citation statements)
references
References 13 publications
2
41
0
Order By: Relevance
“…No significant differences were found for the remaining parameters, with the exception of the baseline HDRS score. According to the comorbidity scale of Liu et al [46], 217 patients out of 290 (74.8%) had comorbidities requiring specific treatment, but not limiting daily activities and exercise.…”
Section: Resultsmentioning
confidence: 99%
“…No significant differences were found for the remaining parameters, with the exception of the baseline HDRS score. According to the comorbidity scale of Liu et al [46], 217 patients out of 290 (74.8%) had comorbidities requiring specific treatment, but not limiting daily activities and exercise.…”
Section: Resultsmentioning
confidence: 99%
“…Exclusion criteria were previous cerebrovascular accidents, subarachnoid hemorrhage, dementia (according to the DSM-III-R definition) [26], presence of other chronic disabling pathologies (i.e., severe Parkinson’s disease, polyneuropathy, severe cardiac, liver or renal failure, cancer, limb amputation), grade 5 in cardiovascular and/or pulmonary items of Liu’s Comorbidity Scale (CS) [27, 28]. …”
Section: Methodsmentioning
confidence: 99%
“…Subjects had to fulfill the following inclusion criteria: (1) ASIA Impairment Scale grades A, B, or C and wheelchair-dependent in daily living, (2) training periods of at least 1 month for orthotic gait as an in-patient, (3) completion of gait training during in-patient rehabilitation, and (4) the presence of no comorbidity that forced patients to lessen the training dose. 23 The subject group consisted of 36 men and nine women with a mean age of 34.0 years (range 16-68 years). Of these patients, 13 used the Walkabout, four used the gear joint orthosis, and 28 used the Primewalk as the medial hip joint.…”
Section: Subjectsmentioning
confidence: 99%